OpenAI reportedly missed revenue and user targets -- these 2 stocks could be big winners

The leading AI lab may be feeling the pressure from competition.

The OpenAI Trial That Could Rewrite How AI Companies Are Built

The Musk v. Altman trial tests whether OpenAI’s for‑profit shift was legal — a ruling that could reshape how AI labs raise ...
Futurism

If OpenAI Loses This Trial, It Could Effectively Be Eliminated in Its Current Form

The anxiously-awaited trial between Elon Musk and OpenAI could have vast implications for the entire AI industry.

OpenAI Misses Expectations -- Should Tech Investors Worry?

OpenAI reportedly missed its own growth and revenue expectations, causing companies with large deals with the AI giant to ...

Musk testifies for a second day in a suit that could change artificial intelligence

Elon Musk took the stand for a second day of testimony against OpenAI and its leaders in a lawsuit that could reshape the ...
The News International

Anthropic nears $1.5B joint venture with Blackstone, Goldman Sachs to rival OpenAI

Anthropic is set to finalize a deal related to a new joint venture with major Wall Street firms including Goldman Sachs, ...

Investors Should Buy the Stocks of These 3 OpenAI Partners Regardless of What Happens to OpenAI

Amazon, CoreWeave, and Oracle can thrive with or without deals from OpenAI.

OpenAI Wants to Go Public. First Sarah Friar Needs to Get It to Grow Up.

The chief financial officer is managing Sam Altman—and ambitions for one of the biggest IPOs ever.
Hosted on MSN

OpenAI CFO urges IPO delay to 2027 amid $1.15T costs

OpenAI’s CFO Sarah Friar has recommended delaying the company’s IPO from late 2026 to mid-to-late 2027 due to missed revenue targets and massive fixed infrastructure costs exceeding $1.15 trillion.